
Shadow World Impulsive: 4. Big Pharma, Big Secret
Feb 13, 2026
A reporter chases whistleblowers and leaked internal documents from a major pharma firm. Stories of patients developing extreme impulse control problems after taking dopamine agonist drugs are recounted. The investigation reveals a years‑long gap between company knowledge and public warnings. Legal battles and personal fallout from undisclosed side effects are explored.
AI Snips
Chapters
Transcript
Episode notes
Family Devastated By Medication-Driven Scam
- Freddie describes his father Bill becoming reckless, using pornography and losing £300,000 to a romance scam after being prescribed a dopamine agonist.
- Bill continued sending money and was manipulated by professional scammers, leaving Freddie to try to stop further harm.
Early Internal Report Predated Public Warnings
- Noel obtained a 2003 GSK internal report linking Rapinarol to increased libido, including cases of sexual assault and deviant sexual behaviour.
- The report recommended adding the symptom to side effects years before patient leaflets warned about impulse control disorders.
Hypersexuality Reversed By Stopping Medication
- Steve hid hypersexual spending and cam-girl bills from his wife while on Rapinarol and only confessed after being confronted by his Parkinson's nurse.
- Stopping the drug produced an immediate 'light switch' effect and the compulsion vanished for him.
